ASND

252.7301.26%
JM

Jan Moller Mikkelsen

President, CEO, Member of Executive Board & Executive Director

Mr. Jan Moller Mikkelsen is President, CEO, Member of Executive Board & Executive Director of Ascendis Pharma A/S from December 2007. He joined the Ascendis Pharma A/S in December 2007. He was Chairman of the Board of Hummingbird Bioscience Pte. Ltd. from November 2021 to August 2026. He was Non-Executive Director of VISEN Pharmaceuticals (Shanghai) Co., Ltd since March 27, 2021 until July 2025 and served as its Director since November 07, 2018. He had been Non-Executive Director at VISEN Pharmaceuticals since November 7, 2018 until June 27, 2025. He is Senior Advisor of Frazier Life Sciences Management, LP. He joined the Frazier Life Sciences Management, LP in 2022. He is Director of Eyconis, Inc. He is Senior Advisor of Frazier Management, L.L.C. He joined the Frazier Management, L.L.C. in 2022. He was Senior Advisor of Vivo Capital, LLC until 2021. He was employed at Vivo Capital, LLC until 2021. He focused on United states. He was Director of Nuevolution AB (publ). He was President and Chief Executive Officer of Veloxis Pharmaceuticals A/S. He was Unit President of Maxygen, Inc. He was Managing Director of Maxygen ApS. He was Chairman of HyScite Discovery. He was Member of Advisory Team of NB Capital ApS. He was Director of Protein Discovery of Novo Nordisk A/S. He has M.S. in Biochemistry from Syddansk Universitet.

Positions